$19.29
-0.37 (-1.88%)
Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL)
CAPS Rating:
A specialty biopharmaceutical company with a focus on developing and marketing products to urologists, endocrinologists, orthopedists and select primary care physicians.
RSS Headlines
Fool UK